Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer.

ABSTRACT:

Importance

Agreement between patient- and practitioner-reported toxic effects during chemoradiotherapy for head and neck cancer is unknown.

Objective

To compare patient-reported symptom severity and practitioner-reported toxic effects among patients receiving chemoradiotherapy for head and neck cancer.

Design, setting, and participants

Forty-four patients participating in a phase 2 trial of deintensified chemoradiotherapy for oropharyngeal carcinoma were included in the present study (conducted from February 8, 2012, to March 2, 2015). Most treatment (radiotherapy, 60 Gy, with concurrent weekly administration of cisplatin, 30 mg/m2) was administered at academic medical centers. Included patients had no prior head and neck cancers, were 18 years or older, and had a smo

SUBMITTER: Falchook AD 

PROVIDER: S-EPMC5928525 | biostudies-literature | 2016 Jun

REPOSITORIES: biostudies-literature